title: The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel.
authors: 1st Department of Cardiology, 'Hippokration' Hospital, University of Athens Medical School, Athens, Greece. Electronic address: drtousoulis@hotmail.com.
authors: Dimitris
authors: D
authors: Tousoulis
authors: Gerasimos
authors: G
authors: Siasos
authors: Marina
authors: M
authors: Zaromitidou
authors: Evangelos
authors: E
authors: Oikonomou
authors: Konstantinos
authors: K
authors: Maniatis
authors: Stamatios
authors: S
authors: Kioufis
authors: Eleni
authors: E
authors: Kokkou
authors: Athanasios G
authors: AG
authors: Papavassiliou
authors: Christodoulos
authors: C
authors: Stefanadis
mesh_terms: D000368:Aged; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000097:blood / Q000139:chemically induced / Q000235:genetics; D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000097:blood* / Q000188:drug therapy / Q000235:genetics*; D065731:Cytochrome P-450 CYP2C19; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D013988:Ticlopidine
keywords: Clopidogrel; Coronary artery disease; Platelet function; Polymorphism